PTPRC and neoplasm: They are attributed to the chemokine impact on various populations of anti-tumor immune cells, including upregulating the number of CD45+ leukocytes in the tumor [39] and recruiting cytotoxic T and NK cells into the tumor microenvironment (TME) [40,41].